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Wnt signaling affects fundamental development
pathways and, if aberrantly activated, promotes the
development of cancers. Wnt signaling is modulated
by different factors, but whether the mitochondrial
energetic state affects Wnt signaling is unknown.
Here, we show that sublethal concentrations of
different compounds that decrease mitochondrial
ATP production specifically downregulate Wnt/
b-catenin signaling in vitro in colon cancer cells and
in vivo in zebrafish reporter lines. Accordingly, fibro-
blasts from a GRACILE syndrome patient and a
generated zebrafish model lead to reduced Wnt
signaling. We identify a mitochondria-Wnt signaling
axis whereby a decrease in mitochondrial ATP re-
duces calcium uptake into the endoplasmic reticu-
lum (ER), leading to endoplasmic reticulum stress
and to impaired Wnt signaling. In turn, the recovery
of the ATP level or the inhibition of endoplasmic retic-
ulum stress restores Wnt activity. These findings
reveal a mechanism that links mitochondrial ener-
getic metabolism to the control of the Wnt pathway
that may be beneficial against several pathologies.INTRODUCTION
Mitochondria are central organelles for both cell survival and
death. Targeting mitochondrial metabolism to specifically trigger
the release of cytochrome c and thus to induce apoptosis in can-Cell Re
This is an open access article under the CC BY-Ncer cells is emerging as a successful strategy (Fulda et al., 2010).
In contrast, how mitochondrial metabolism affects downstream
signaling pathways in the context of proliferation and/or differen-
tiation is still poorly defined.
An important signaling pathway affecting cell fate is the canon-
icalWnt signaling,which relies on the progressive accumulation of
unphosphorylatedb-catenin in the cytoplasmand its translocation
into thenucleus toactasa transcriptional co-activatorofaplethora
of transcription factors, including the T cell factor-lymphoid
enhancer factor (TCF-LEF) family. In the absence of Wnt ligands,
b-catenin is degraded by the destruction complex, which includes
glycogen synthase kinase 3b (GSK3b) (Morris and Huang, 2016).
Aberrant Wnt/b-catenin signaling is often constitutively acti-
vated in cancer cells (e.g., Morris et al., 2010), including breast
(Nusse and Varmus, 1982) and colon cancers (Korinek et al.,
1997), thereby actively participating in conferring unlimited pro-
liferative potential to these pathologic cells. Small molecules in-
hibitingWnt signaling recently entered clinical testing (Zhang and
Lum, 2018). Alternatively, activation of Wnt-induced pathways
was proposed as a strategy to promote axonal growth after injury
(Garcia et al., 2018). While Wnt signaling is well known to influ-
ence mitochondrial function (e.g., Bernkopf and Behrens,
2018; Rasmussen et al., 2018; Yoon et al., 2010), the possibility
that pharmacological agents affectingmitochondrial metabolism
specifically and systematically modulate Wnt signaling has not
been explored so far. Here, we show that the fine-tuning of mito-
chondrial function leads toWnt signalingmodulation both in vitro
and in vivo, and we identify the underlying mechanism.
RESULTS
TomonitorWnt signaling in intact cells, human embryonic kidney
(HEK293) cells were transiently transfected with a TCF-LEFports 28, 1949–1960, August 20, 2019 ª 2019 The Author(s). 1949
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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luciferase reporter plasmid (Figure 1A). As basal Wnt signaling is
relatively low in these cells (Figure S1A), the GSK3 inhibitor
CHIR99021 was used to enhance b-catenin stabilization and
activate Wnt signaling. The tankyrase inhibitor XAV939, a known
Wnt-signaling inhibitor that stabilizes Axin and thus promotes the
degradation of cytosolic b-catenin, was used as positive control
(Figure 1A) (Shimizu et al., 2012). To test whether the alteration of
mitochondrial metabolic stress elicited by different means could
alter Wnt signaling, cells were incubated for 8 h with sublethal
doses (Figure S1B) of different drugs known to alter mitochon-
drial function. For our study, we selected a few compounds on
the basis of their known effects on respiratory chain complexes
or K+ fluxes or in their activity as an uncoupler agent (listed
below).
The classical uncoupler carbonilcyanide p-trifluoromethoxy-
phenylhydrazone (FCCP) and inhibitors of mitochondrial
respiratory chain complexes, namely rotenone for complex I,
thenoyltrifluoroacetone (TTFA) for complex II, antimycin A for
complex III, and oligomycin for complex V,were used (Figure 1A).
Similar concentration ranges were directly shown to inhibit com-
plex I, II, III, and V activities in HEK293 cells (e.g., Chre´tien et al.,
2018), without being toxic at the dosage used (Chre´tien et al.,
2018; Figures S1B and S1C). According to a vast amount of
data from the literature, these compounds markedly alter bioen-
ergetic efficiency in mitochondria (including oxygen consump-
tion rate, ATP production, and reactive oxygen species [ROS]
release) (Nicholls, 2013).
Since mitochondrial potassium fluxes also affect the mem-
brane potential across the inner mitochondrial membrane and,
as a consequence, trigger the release of ROS (Laskowski
et al., 2016; Szabo and Zoratti, 2014), the K+ ionophore valino-
mycin and K+/H+ exchangers salinomycin and nigericin, all
shown to reach themitochondrial inner membrane (e.g., Manago`
et al., 2015 and references therein), were exploited (Figure 1A).
In addition, (3-(4-(4-((7-oxo-7H-furo[3,2-g]benzopyran-4-yl)oxy)
butoxy)phenyl)propyl)triphenyl phosphonium iodide (PAPTP)
and (3-(((4-(4-((7-oxo-7H-furo[3,2-g]benzopyran-4-yl)oxy)butoxy)
phenoxy)carbonyl) amino) propyl) triphenylphosphonium iodide
(PCARBTP), two recently described specific mitochondria-tar-
geted derivatives of 5-(4-Phenoxybutoxy)psoralen (PAP-1),
were used (Figure 1A). PAP-1 is an inhibitor of the K+ channelFigure 1. Mitochondrial Fitness Fine-Tunes Wnt Signaling in Human
Zebrafish
(A) Canonical Wnt signaling activity based on TCF-LEF-dependent transcription
signaling was enhanced using 3 mM CHIR99021 (CHIR). Cells were then treated f
XAV939 (XAV) as positive control; MgTx, ShK, ChTx (1 mM); PAP-1 (20 mM) + cyclo
0.5 mM nigericin (Nige), 1 mM valinomycin (Valino); and 2 mM FCCP; 5 mM rotenone
The luciferase signal was normalized with respect to the signal given by b-gal, wh
percentage of luciferase signal related to the ‘‘ref.’’ Values are means ± SEMs (n
(B and C) Reduction of protein levels of b-catenin and its target genes LEF1 an
(n = 6; means ± SEMs) is reported in (C).
(D and E) GFP fluorescent zebrafish Tg(7xTCFX.lasiam:EGFP)ia4 Wnt-dependen
0.2%, 20 mM XAV, 1 mM Salino, 1.5 mM PAPTP, 5 mM PCARBTP, 50 mM TTFA, an
images are reported in (D), while fluorescence quantification is shown in (E) (m
zebrafish embryos treated for each condition. Bars, 1.5 mm.
(F) Zebrafish b-catenin (Zb-catenin) protein level from embryos treated as (D) and
values are indicated as the percentage of the ‘‘ref’’ (n = 3; means ± SEMs).
Statistical significance (ANOVA) was determined as *p < 0.05, **p < 0.01, and ***Kv1.3 that is expressed in different cells (Perez-Verdaguer
et al., 2016), including HEK293 (Ponce et al., 2018). Both com-
pounds were shown to inhibit the mitochondria-located Kv1.3
to trigger mitochondrial ROS release and changes in mitochon-
drial membrane potential (Leanza et al., 2017).
In our experiments, all of the above compounds significantly
reduced theWnt reporter activity (Figure 1A), while the luciferase
enzymatic activity itself was not affected (Figure S1C). Similar re-
sults were obtained when Wnt signaling was induced by consti-
tutively active b-catenin or by Wnt3A ligand expression (Figures
S1D and S1E). While the K+ ionophores act both at the plasma
membrane and the mitochondrial inner membrane, the speci-
ficity of the mitochondria-Wnt axis was evident from experi-
ments using respiratory chain inhibitors. Comparison of the
Wnt-reducing effects of the membrane permeant Kv1.3 inhibi-
tors with those of the membrane impermeant Kv1.3 blockers
(margatoxin [MgTx], stichodactyla toxin [ShK], and charybdo-
toxin [ChTx]), which did not affect Wnt signaling (Figure 1A),
also strongly points to a mitochondria-Wnt axis. The drugs spe-
cifically affected Wnt signaling, since neither Notch nor the
Hippo pathways were modulated by the used compounds (Fig-
ures S1F and S1G). This also further indicates the lack of toxicity
of the drugs at the concentrations used. Downregulation of Wnt
signaling was also confirmed by western blot; the protein levels
of b-catenin and two of its target genes, lymphoid enhancer-
binding factor 1 (LEF1) and the receptor tyrosine kinase MET,
were reduced (Figures 1B and 1C). Downregulation of the gene
transcription of two Wnt-dependent genes, Cyclin D1 and Dick-
kopf 1 (DKK1), was also observed, while transcription of b-cate-
nin remained unaffected (Herbst et al., 2014) (Figure S1H).
To confirm our findings also in in vivo experiments, we used
the well-established Tg(7xTCFX.lasiam:EGFP)ia4 zebrafish re-
porter line for canonical Wnt signaling (Moro et al., 2012). Suble-
thal doses of the above compounds significantly diminishedWnt
reporter activity, with similar effects to XAV939 (Figures 1D and
1E), and the b-catenin protein level was reduced in developing
embryos upon treatment (Figure 1F). In accordance with
reduced Wnt signaling, the sagittal axis of the treated larvae
was shortened in comparison to the control animals, phenoco-
pying the well-known effect of the Wnt inhibitor XAV939 on em-
bryo development (Shimizu et al., 2012) (Figure 1D).Embryonic Kidney HEK293 Cells and in Wnt-Dependent Reporter
was assayed in HEK293 cells. These cells were either left untreated or Wnt
or 8 h with the following compounds: 0.1% DMSO, as negative control; 10 mM
sporin H (CSH) (4 mM); 1 mMPAPTP, 5 mMPCARBTP; 5 mMsalinomycin (Salino),
(Rot), 0.5 mM TTFA, 1.8 mM antimycin A (Anti), and 1.2 mM oligomycin (Oligo).
ich was co-transfected with TOPflash plasmid. The values are reported as the
= 8).
d MET are shown in representative western blots (B). Densitometric analysis
t reporter fishes were treated for 15 h with the following compounds: DMSO
d 0.12 mM Oligo. Representative bright-field and epifluorescence microscopy
eans ± SEMs). The numbers reported on the graph represent the number of
(E) was determined by western blot. The quantification is reported below. The
p < 0.001.
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As a control of the specificity of the effects of the drugs onWnt
signaling, three further pathways were studied in vivo: (1) Sonic
Hedgehog (Shh), an important signaling pathway involved in
cellular specification and proliferation (Figure S1I); (2) oligoden-
drocyte transcription factor 2 (Olig2), required for oligodendro-
cyte and motor neuron specification in the spinal cord
(Figure S1J); and (3) the erythroid transcription factor Gata 1 (Fig-
ure S1K), which plays a critical role in the normal development of
hematopoietic cell lineages. In none of these cases did downre-
gulation occur upon treatment, indicating in vivo specificity as
well as a lack of toxicity of the drugs at the concentrations used.
All of these chemicals caused similar in vitro and in vivo effects
on Wnt signaling activity; however, at the molecular level, they
have very different actions, leading us to wonder what common
mechanism could be responsible for the regulation of Wnt. The
depolarization of the mitochondrial membrane potential
(observed only for valinomycin, PAPTP, PCARBTP, FCCP, and
antimycin A, not for salinomycin and nigericin) or matrix acidifi-
cation (takes place only with salinomycin, nigericin, PAPTP,
and antimycin) is not a common effect of these drugs, according
to previous data (e.g., Forkink et al., 2015; Leanza et al., 2017;
Manago` et al., 2015). Hydrogen peroxide was shown to activate
canonical Wnt signaling (Funato et al., 2006), but in our case,
some of the drugs induce ROS release (antimycin A, valinomy-
cin, FCCP, PAPTP, PCARBTP; Leanza et al., 2017; Manago`
et al., 2015), while others do not (nigericin or salinomycin; Man-
ago` et al., 2015) within the examined timescale. Further possible
links, such as b-catenin activation by serine 552 phosphorylation
via protein kinase A (PKA) or serine-threonine protein kinase Akt
(Lee et al., 2010) (Figure S2A) and fatty acid biosynthesis or
oxidation as the readout of AMP kinase (AMPK) activity that is
regulated by the cytoplasmic ATP:AMP ratio (Ha et al., 1994)
(Figure S2B), have been explored. However, none of these
modulatory events changed with any of the drugs that were
able to decrease Wnt signaling.
All of the drugs, except XAV939 and thapsigargin, that were
used as negative controls, however, reduced mitochondrial
ATP production (Figure 2A) (assessed using 2-deoxyglucose toFigure 2. Mitochondria-Wnt Signaling Axis Is Mediated by Reduced M
Induction in HEK293 and Colon Cancer Cells
(A) Mitochondrial ATP content was measured in HEK293 cells treated as in Figur
(Thapsi) was used at 1 mM (n = 4; means ± SEMs).
(B) Canonical Wnt signaling activity was assayed in HEK293 cells as in Figure 1A.
atractyloside (Atracty).
(C) Endoplasmic reticulum Ca2+ levels in HEK293 cells treated for 6 h as in (B) or Fi
shown in the upper panel, while the quantification at steady state is reported at b
and analysis is related to the ‘‘ref.’’
(D) b-Catenin and LEF1 reduction was measured in HEK293 cells by western
quantification is reported at right (n = 4; means ± SEMs).
(E) Induction of endoplasmic reticulum stress was shown in HEK293 cells by incre
(D) and Figure 1A. A representative blot is shown in the upper panel, while the q
(F) Endoplasmic reticulum stress induction was studied in HEK293 cells transfe
luciferase reporter assay. The values are reported as the percentage of luciferas
(G) Canonical Wnt signaling activity based on TCF-LEF-dependent transcription w
(n = 3; means ± SEMs).
(H) Endoplasmic reticulum Ca2+ levels in HCT116 cells after a 6-h treatment with
(I) b-Catenin and LEF1 reduction and endoplasmic reticulum stress induction
Quantification is reported in Figure S2G.
Statistical significance (ANOVA) was determined as *p < 0.05, **p < 0.01, and ***block the contribution of glycolysis to the overall ATP level in
the cells). This result led us to hypothesize that the effects on
Wnt weremediated by reducedmitochondria-derived ATP levels
independently of the overall ATP concentration within the cells.
In agreement with our hypothesis, atractyloside, an inhibitor of
the adenine nucleotide transporter (ANT) that exports synthe-
tized ATP from the mitochondrial matrix, was able to reduce
Wnt signaling even when glycolysis was active (Figure 2B).
Thanks to the crucial cross-talk between mitochondria and the
endoplasmic reticulum (ER) (Rizzuto et al., 2012), specifically
themitochondrial ATP pool seems to be important for the activity
of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase
(SERCA), since its function was shown to be inhibited by the
reduced amount of mitochondrial ATP in the interstitial spaces
in the mitochondria-associated membranes (MAMs) (De Marchi
et al., 2011; Madreiter-Sokolowski et al., 2016). In accordance
with the expected reduced activity of SERCA, we observed a
reduction in calcium (Ca2+) levels in the endoplasmic reticulum
upon treatment with the drugs able to reduce mitochondrial
ATP production or its export to the cytosol (atractyloside) (Fig-
ure 2C), without modulation of the non-canonical Wnt/Ca2+
pathway (Figure S2C). Independent of the addition of 2-deoxy-
glucose, oligomycin and PAPTP reduced Ca2+ uptake in the
endoplasmic reticulum, further underlining the importance of
mitochondrial ATP in this pathway (Figure S2D). The widely
used endoplasmic reticulum-targeted aequorin was exploited
to monitor dynamic changes in free Ca2+ concentration in the
endoplasmic reticulum of intact cells (Montero et al., 1995).
Endoplasmic reticulum function modulators thapsigargin and
tunicamycin equally elicited Wnt downregulation (Figures 2B
and 2D). Thapsigargin disrupts the Ca2+ storage of endoplasmic
reticulum by blocking SERCA and thus Ca2+ reuptake into the
endoplasmic reticulum lumen, thereby depleting endoplasmic
reticulum Ca2+ (Figure 2C). Tunicamycin, a highly specific endo-
plasmic reticulum stress inducer, was also able to decrease Wnt
signaling (Figure 2B). To further validate the importance of the
endoplasmic reticulum-mitochondria proximity in this pathway,
we transiently overexpressed Mitofusin2 (MFN2) in HeLa cellsitochondrial ATP Synthesis and Endoplasmic Reticulum (ER) Stress
e 1A, but in a medium containing 5 mM 2-deoxyglucose (2-DG). Thapsigargin
Cells were treated with 1 mM Thapsi, 0.5 mg/mL tunicamycin (Tunica), or 10 mM
gure 1A. Representative traces of the endoplasmic reticulumCa2+ reuptake are
ottom (n = 3; means ± SEMs). The values are reported as Ca2+ concentrations,
blot after treatment with Thapsi. A representative blot is shown at left, while
ased phosphorylation of eIF2a and enhanced expression of ATF4 treated as in
uantification related to the ‘‘ref’’ is reported at bottom (n = 3; means ± SEMs).
cted with a F-XBP1DDBD plasmid and treated as in (B) and Figure 1A with a
e signal related to the ‘‘ref’’ (n = 5; means ± SEMs).
as assayed in HCT116 cells as in Figure 1A for 8 h, without the addition of CHIR
the indicated compounds (as in G). Analysis as in (C) (n = 3, means ± SEMs).
were measured in HCT116 cells by western blot after treatment as in (G).
p < 0.001.
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Figure 3. Mitochondrial Fitness Fine-Tunes Wnt Signaling in Human Fibroblasts and in Respiratory Chain Complex III Deficiency Zebrafish
Models
(A) Reduction of the protein levels of b-catenin and its target genes TCF7 and CD44 and endoplasmic reticulum stress induction was observed in human
immortalized fibroblasts. Protein extracts obtained from healthy donors (WT) or GRACILE patients (bcs1lR73C/F368I) were used. A representative blot and
quantification are shown (left and right, respectively; n = 3; means ± SEMs).
(B) Total protein extracts from human immortalized fibroblasts from healthy donors treated overnight with 0.2% DMSO or 1 mM Anti were analyzed by western
blot. The quantification is shown at right (n = 3; means ± SEMs).
(C) Transient knockdown of the respiratory chain complex III was performed by two independent splicing morpholinos against Ttc19 and Bcs1l mRNAs
(Ttc19 spMO and Bcs1l spMO); a standard control morpholino was also used. Bright-field images of morphants are reported. Bars, 1 mm.
(D) Respiratory efficiency of morpholino-injected embryos (pool of 15 embryos) was analyzed by the Oxygraph+ instrument. Oxygen concentration in themedium
and the consumption rate are plotted.
(legend continued on next page)
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(Figure S2E). MFN2 overexpression enhanced the number of
endoplasmic reticulum-mitochondria contact sites as docu-
mented by the quantification of green fluorescent dots (Fig-
ure S2F) (Cieri et al., 2018; Csorda´s et al., 2010; Giacomello
et al., 2010). Under the same MFN2 overexpression conditions,
we monitored endoplasmic reticulum Ca2+ uptake, as in Fig-
ure 2C (Figure S2G). We found that HeLa cells overexpressing
MFN2 reached a higher plateau level of endoplasmic reticulum
Ca2+ in the lumen than mock transfected cells, indicating that
enhanced endoplasmic reticulum-mitochondria tethering is
able to support SERCA pump activity in refilling endoplasmic re-
ticulum stores. No variations in SERCA or luminal endoplasmic
reticulum Ca2+-buffering proteins (e.g., calreticulin, calnexin)
expression have been observed upon the transient overexpres-
sion of MFN2 (Figure S2E).
The reduced Ca2+ content in the endoplasmic reticulum re-
sulted in endoplasmic reticulum stress, as expected (Jung and
Choi, 2016; Savignac et al., 2014) and as indicated in our exper-
iments by classical endoplasmic reticulum stress-related events
such as increased phosphorylation of the eukaryotic initiation
factor 2 (eIF2a), upregulation of both activating transcription fac-
tor 4 (ATF4) and binding immunoglobulin protein (BiP/GRP78, an
endoplasmic reticulum chaperone), and by an increased X-box-
binding protein 1 (XBP-1) transcriptional activity (Figures 2E, 2F,
and S2H) (for review, see, e.g., Rozpedek et al., 2016). Endo-
plasmic reticulum stress has previously been shown to trigger
Wnt signaling downregulation, since ATF4 enhances the expres-
sion of transcription factors, including CHOP (CCAAT/enhancer-
binding protein homologous protein)/GADD153 (growth arrest
and DNA damage-inducible protein) (Wek et al., 2006). CHOP
functions as a specific inhibitor of Wnt-T cell factor (TCF)
signaling (e.g., Horndasch et al., 2006; Verras et al., 2008), since
it prevents the binding of TCF to its DNA recognition site. Even
though the Akt kinase expression level did not change, endo-
plasmic reticulum stress-induced phosphorylation of Akt at
serine 473 occurred, as expected (Yung et al., 2011) (Figures
S3A–S3C). Akt activation, however, did not significantly affect
GSK3b expression and phosphorylation when Wnt signaling
was enhanced by the ligand Wnt3a (Figures S2A–S2C).
AsWnt signaling is constitutively upregulated in colon cancers
(thus, no activation by CHIR99021 is required), the HCT116 co-
lon cancer line was used to show that mitochondrial ATP deple-
tion (Figure S4A) induced reduction in the calcium levels in the
endoplasmic reticulum set by SERCA (Figure 2H) and endo-
plasmic reticulum stress (Figures 2I and S4C). All of the drugs
used reduced Wnt signaling in these tumor cells already at sub-
lethal concentrations (Figure S4B) andwithin 8 h after application
(Figures 2G, 2I, and S4C). In these cells, the effects of XAV939(E) Knock down of the respiratory complex III was performed in Tg(7xTCFX.lasia
epifluorescence quantification was reported in the graph below; dots and number
was determined as *p < 0.05, **p < 0.01, and ***p < 0.001). Bars, 1 mm.
(F) Mito-Wnt axis is an important pathway in which mitochondrial dysfunction (
mitochondrial ATP synthesis, which directly affects Ca2+ uptake by regulating SE
endoplasmic reticulum (3), leading to endoplasmic reticulum stress induction by t
CHOP (4), which are able to modulate Wnt signaling by a still-debated mechanism
transcription of Wnt target genes, leading to the control of cell proliferation, me
opment and the spreading of metastasis (6). Finally, a possible feedback mechan
indicated by experiments shown in Figure S2D, glycolysis also contributes to theand the other compounds were less pronounced on the b-cate-
nin level compared to HEK293 cells (Li et al., 2015), most likely
due to a mutation in the b-catenin itself in HCT116 (Ichimanda
et al., 2018; Shikata et al., 2017). Similar results were obtained
in another colon cancer line, DLD1, characterized by constitu-
tively active Wnt signaling due to a truncation in adenomatous
polyposis coli (APC) (Homfray et al., 1998; Kishida et al., 1998),
concerning viability upon treatment (Figure S4D), reduction of
Wnt signaling (Figures S4E andS4G), ATP depletion (Figure S4F),
and endoplasmic reticulum stress (Figure S4G).
To genetically validate the direct functional epistasis between
mitochondrial function and endoplasmic reticulum stress-Wnt
signaling, we used fibroblasts obtained from a patient with
GRACILE syndrome caused by respiratory chain complex III
deficiency. This patient is characterized by composed heterozy-
gous mutations of bcs1l (bcs1lR73C/F368I), encoding an assembly
factor of complex III (Fernandez-Vizarra et al., 2007). These cells
exhibited an increased endoplasmic reticulum stress (Figure 3A)
and downregulated b-catenin, its related transcription factor
TCF7, and CD44 (Wnt targets; Herbst et al., 2014) protein levels
compared to normal fibroblasts (Figure 3A), which show a similar
phenotype upon treatment with the complex III inhibitor antimy-
cin A (Figure 3B).
To validate and generalize this observation also in vivo, we
generated two independent zebrafishmodels for complex III dis-
eases. By using morpholino-mediated transient knockdown of
two previously identified complex III assembly factors, Bcs1l or
Ttc19 (Bottani et al., 2017; Ghezzi et al., 2011), we observed
reduced respiration as expected (Figure 3D) in addition to
sagittal axis shortening, tail and craniofacial deformity, and lower
pigmentation in comparison to controls (Figure 3C). In both
cases, statistically significant reduction in Wnt signaling was
evident (Figure 3E), confirming in vivo that the genetic modula-
tion of complex III efficiency downregulates Wnt signaling.
The data above suggest that mitochondrial function and ATP
production, by maintaining Ca2+ stores in the endoplasmic retic-
ulum, relieve endoplasmic reticulum stress and enable efficient
Wnt signaling (Figure 3F). To validate this hypothesis, we rein-
stalled mitochondrial ATP synthesis by supplementing cells
with phosphoenolpyruvate (PEP) or creatine (Figure 4A), and
we observed rescued Wnt activity in cells where the ATP level
was markedly reduced by treatment with PAPTP (Figures 2A
and 4B). Reducing endoplasmic reticulum stress by 4-phenyl
butyric acid (4-PBA) (Ben Mosbah et al., 2010) equally re-acti-
vated Wnt, even in the presence of PAPTP (Figure 4B). Finally,
treatment with phosphoenolpyruvate, creatine, or 4-PBA of
bcs1lR73C/F368I fibroblasts rescued not only mitochondrial ATP
content (phosphoenolpyruvate and creatine; Figure 4C) butm:GFP)ia4 by Ttc19 spMO and Bcs1l spMO and compared to the control. GFP
s represent treated embryos (means ± SEMs). Statistical significance (ANOVA)
1), due to mutated genes or to pharmacological treatment, leads to reduced
RCA in the endoplasmic reticulum (2). This in turn decreases Ca2+ levels in the
he phosphorylation of eIF2a and activation of its downstream factors ATF4 and
(5). This modulation could regulate several downstream events such as gene
tabolic adaptation, and cell migration, in particular, modulating cancer devel-
ism of reduced Wnt signaling can further regulate mitochondrial activity (7). As
regulation of Ca2+ uptake into the endoplasmic reticulum.
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Figure 4. Increased Mitochondrial ATP Production or Endoplasmic Reticulum Stress Inhibition Rescues Wnt Signaling
(A) Mitochondrial ATP content was measured in HEK293 cells, after treatment with 1 mM creatine (CRE) or 60 mM phosphoenolpyruvate (PEP) for 30 min.
Furthermore, Wnt signaling was induced by co-administration of 3 mM CHIR. The analysis was conducted as in Figure 2A (n = 3; means ± SEMs).
(B) Canonical Wnt signaling activity based on TCF-LEF-dependent transcription was assayed in HEK293 cells, as in Figure 1A. Cells were pre-treated for 30 min
with CRE or phosphoenolpyruvate or for 2 h with 0.5 mM of the endoplasmic reticulum stress inhibitor 4-phenyl butyric acid (4-PBA) before addition and
incubation with or without 1 mM PAPTP for a further 8 h (n = 3; means ± SEMs).
(C) Mitochondrial ATP was measured and analyzed in human immortalized fibroblasts from healthy donors (WT) or a GRACILE patient (n = 3). Cells were pre-
treated as in (A).
(D) b-Catenin and CD44 recovery were measured in bcs1lR73C/F368I fibroblasts by western blot after treatment with the following compounds: 3 mM CHIR, 1 mM
CRE, 0.6 mM phosphoenolpyruvate, or 0.5 mM 4-PBA.
(legend continued on next page)
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also increased the protein levels of b-catenin and CD44 (Fig-
ure 4D) and reduced endoplasmic reticulum stress (Figure 4E).
Finally, we show that in our zebrafish models, the recovery of
Wnt signaling and of the wild-type (WT)-like phenotype and
length can be achieved by the administration of creatine in vivo
(Figures 4F and 4G).
DISCUSSION
The data in the present paper indicate the existence of a mito-
chondrial-Wnt signaling axis, in which mitochondrial ATP plays
a crucial role in fine-tuning this important pathway by allowing
correct SERCA function and appropriate loading of endoplasmic
reticulum with Ca2+ (Figure 3F) to avoid endoplasmic reticulum
stress, which in turn reduces Wnt signaling. The data obtained
with the patients’ fibroblasts are in agreement with the pharma-
cological data in WT cells, indicating that a markedly reduced
mitochondrial ATP level, which can be observed in GRACILE
syndrome fibroblasts due to impaired complex III function, is
linked to increased endoplasmic reticulum stress and reduced
Wnt signaling.
The experimental results reported here show that perturbation
of mitochondrial function using a number of inhibitors can cause
decreased Wnt activity both in vitro and in vivo. Wnt signaling
downregulation is not due to a general toxicity or to an endo-
plasmic reticulum stress-linked inhibition of transcription or
translation, since cell survival was not affected and b-catenin
transcription itself was not decreased upon treatment; several
different proteins such as actin, GSK3a, GSK3b, and Wnt5
were present at the same level in both untreated and treated
samples. In the present study, we investigated the short-term ef-
fects of different compounds used at sublethal concentrations.
We cannot exclude, however, that at much higher concentra-
tions and/or longer incubation times the drugs may induce mito-
chondrial damage and Wnt signaling may increase as part of an
adoptive response, as suggested by Bernkopf et al. (2018).
These investigators observed an increased Wnt signaling 72 h
after the treatment of the cells with a very high dose (100 mM)
of the uncoupler carbonyl cyanide m-chlorophenyl hydrazone
(CCCP) (in contrast to the 2 mM FCCP used here). It must be
mentioned that higher concentrations of the drugs than those
used in this study may also trigger apoptosis (e.g., Leanza
et al., 2017; Manago` et al., 2015).
Some of the drugs used here were shown to have beneficial
effects in the context of cancer development, in which Wnt
signaling plays a crucial role. Oligomycin 10 mM was shown to
inhibit mammosphere formation in MCF7 breast cancer cells
(De Luca et al., 2015), and a sublethal dose (0.5 mg/kg) of oligo-
mycin was able to prevent K-Ras expression-induced tumor
relapse of pancreatic ductal adenocarcinoma even in vivo (Viale
et al., 2014). Valinomycin, salinomycin, and nigericin were re-(E) Endoplasmic reticulum stress rescue wasmeasured in bcs1lR73C/F368I fibroblas
right (n = 3; means ± SEMs).
(F and G) Zebrafish morphants for Ttc19 (F) and Bcs1l (G) were obtained as in F
epifluorescence are shown. The sagittal length and GFP epifluorescence quantifi
numbers represent treated embryos). Bars, 1.5 mm.
Statistical significance (ANOVA) was determined as *p < 0.05, **p < 0.01, and ***ported to inhibit cancer stem cell survival (Manago` et al.,
2015). PAPTP and PCARBTP were shown to induce a drastic
reduction in tumor size in vivo in the case of melanoma and
pancreatic ductal adenocarcinoma at 5 nmol/g mouse (Leanza
et al., 2017). While previous sporadic observations linked the ef-
fect of some of the drugs used here (e.g., potassium ionophores)
to Wnt signaling, the present work shows that such regulation
takes place efficiently in vivo and provides a rationale for a com-
mon mechanism of action.
Our results indicate that SERCA activity is crucial for Wnt
signaling both in vitro and in vivo, in agreement with previous
suggestions (Lu and Carson, 2009; Lu et al., 2011). ATP regu-
lates SERCA function in the mitochondria-associated mem-
branes (De Marchi et al., 2011; Madreiter-Sokolowski et al.,
2016), and we show that mitochondrial ATP is involved in the
proposed pathway, since both endoplasmic reticulum calcium
level and Wnt signaling are significantly reduced even when
glycolytic ATP is available, but ATP export from the matrix is
blocked using atractyloside, an ANT inhibitor. Our results also
suggest that the genetic modulation of endoplasmic reticulum-
mitochondria tethering by overexpressing MFN2 increases the
endoplasmic reticulum Ca2+ content. Although this effect appar-
ently cannot be ascribed to an increased SERCA expression
and/or decreased expression of some of the endoplasmic retic-
ulum proteins involved in Ca2+ buffering, possible changes (e.g.,
in the activity of SERCA depending on the expression of MFN2)
cannot be excluded. Therefore, the precise molecular mecha-
nism that can explain our observation needs to be further
investigated.
In our experiments, a decrease in SERCA function upon
reduction of ATP supplied bymitochondria leads to endoplasmic
reticulum stress. Nevertheless, we cannot exclude that other
factors (e.g., mitochondria-released metabolites) also contribute
to the regulation of this chain of events. Increased endoplasmic
reticulum stress was previously linked to the inhibition of Wnt
signaling via CHOP (Horndasch et al., 2006; Verras et al., 2008)
and has been confirmed also by several other studies (e.g.,
Huang et al., 2018; Shen et al., 2014), but the exact mechanism
linking these events is still debated. Endoplasmic reticulum
stress was proposed to inhibit Wnt signaling by interfering with
the glycosylation of Wnt ligands (Verras et al., 2008), but recent
data point to the endoplasmic reticulum stress-triggered loss
of Wnt signaling occurring at a level downstream of b-catenin
(van Lidth de Jeude et al., 2017). Thus, further work will be
required to understand the fine details of the endoplasmic retic-
ulum stress-Wnt downregulation axis.
Mitochondrial fitness and metabolites are emerging as master
regulators of crucial cellular functions and differentiation. Succi-
nate has recently been discovered to drive thermogenesis in
brown fat tissues (Mills et al., 2018). Mitochondrial ROS regu-
lates myc signaling (Zhang et al., 2017), while mitochondrialts. Representative blots are shown at left, while the quantification is reported at
igures 3C and 3E. Bright-field images of morphants as well as reporter GFP
cation of embryos are reported in the graph below (means ± SEMs; dots and
p < 0.001.
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morphology affects Notch signaling (Kasahara et al., 2013).
Glucosemetabolismwas shown to regulate Yes-associated pro-
tein (YAP)/transcriptional co-activator with PDZ-binding motif
(TAZ), key transcription factors affecting tumor cell proliferation
and aggressiveness (Enzo et al., 2015). Finally, a very recent
report showed that the knockdown of transcription factor A,
mitochondrial (TFAM), a transcription factor that is essential for
mtDNA replication, resulted in the decreased expression of
genes downstream of Wnt/b-catenin signaling (Wen et al.,
2019). Our observations can be of relevance in the context of
cancer therapy, since the induction of mitochondrial dysfunction
leading to a reduced mitochondrial ATP level and possibly to the
consequent inhibition of Wnt-b-catenin signaling can be benefi-
cial against Wnt-dependent cancer progression (Ishii et al.,
2012), even at sublethal concentrations, either alone or in com-
bination therapy with currently used chemotherapeutics (Krus-
pig et al., 2016).
The observation that phosphoenolpyruvate and creatine are
able to increase Wnt signaling by increasing the mitochondrial
ATP level and can rescue the phenotype of complex III disease
zebrafish models can be of clinical relevance in the context of
neurogenesis following injury. The view that increasing neuro-
genesis through activating the Wnt signaling pathway in depres-
sion can preserve brain function is emerging (Lee and Baek,
2017). Benefits of creatine supplementation have been reported
for depression and other CNS diseases (Pazini et al., 2017). A
very recent paper highlighted that creatine supplementation
can prevent, via activation of the Wnt/GSK3b/b-catenin
pathway, chronic mild stress-induced decreases in hippocam-
pal neurogenesis (Leem et al., 2018). However, the underlying
molecular mechanism was not addressed in these papers.
Thus, the information reported in the present article can be of
relevance in the context of both cancer and neurogenesis. In
addition, it suggests that creatine supplementation may have
beneficial effects in the case of complex III disease patients,
who can present with severe neurological deficits.STAR+METHODS
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
b-catenin Sigma-Aldrich Cat#C7082; RRID:AB_258995
b-catenin pS552 Cell Signaling Technology Cat#9566
MET Cell Signaling Technology Cat#8198; RRID:AB_10858224
LEF1 Cell Signaling Technology Cat#2230; RRID:AB_823558
CD44 Cell Signaling Technology Cat#3570; RRID:AB_2076465
GSK3a/b Cell Signaling Technology Cat#5676; RRID:AB_10547140
GSK3a/b pS21/9 Cell Signaling Technology Cat#8566; RRID:AB_10860069
Wnt5a/b Cell Signaling Technology Cat#2530; RRID:AB_2215595
NFATc1 Santa Cruz Biotechnologies Cat#sc-7294; RRID:AB_2152505
Akt Cell Signaling Technology Cat#9272; RRID:AB_329827
Akt pS473 Cell Signaling Technology Cat#4060; RRID:AB_2224726
ACC pS79 Santa Cruz Biotechnologies Cat#sc-271965; RRID:AB_1526014
Bip (GRP78) Cell Signaling Technology Cat#3183; RRID:AB_10695864
eIF2a pS51 Abcam Cat#ab32157; RRID:AB_732117
eIF2a Abcam Cat#ab5369; RRID:AB_304838
ATF4 Santa Cruz Biotechnologies Cat#sc-200; RRID:N.D.
GAPDH Millipore Cat#CB1001; RRID:AB_2107426
b-actin Millipore Cat#MAB1501; RRID:AB_2223041
TCF7 Sigma-Aldrich Cat#WH0006932M1; RRID:AB_1843894
MFN2 Abnova Cat#H00009927-M03; RRID:AB_530127
SERCA Thermo Fisher Scientific Cat#MA3-910; RRID:AB_2227681
Calnexin Stressgen Cat#SPA-860; RRID:AB_2069021
Calreticulin Stressgen Cat#SPA-601; RRID:AB_2038900
Anti-mouse secondary antibody Sigma-Aldrich Cat#A4416; RRID:AB_258167
Anti-rabbit secondary antibody KPL Cat#074-1516; RRID:N.D.
Chemicals, Peptides, and Recombinant Proteins
Cyclosporine H Sequoia Cat#SRP046746c
PAP-1 Sigma Aldrich Cat#P6124
Staurosporine Sigma Aldrich Cat#S4400
CHIR99021 Sigma Aldrich Cat#SML1046
XAV939 Sigma Aldrich Cat#X3004
Cyclopamine Sigma Aldrich Cat#C4116
Valinomycin Sigma Aldrich Cat#V0627
Salinomycin Sigma Aldrich Cat#S4526
Nigericin Sigma Aldrich Cat#N7143
Rotenone Sigma Aldrich Cat#R8875
2-Thenoyltrifluoroacetone (TTFA) Sigma Aldrich Cat#T27006
Antimycin A Sigma Aldrich Cat#A8674
Oligomycin Sigma Aldrich Cat#75351
carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) Sigma Aldrich Cat#C2920
Atractyloside Sigma Aldrich Cat#A6882
Thapsigargin Sigma Aldrich Cat#T9033
Tunicamycin Sigma Aldrich Cat#T7765
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Creatine Sigma Aldrich Cat#C3630
Phosphoenolpyruvate Sigma Aldrich Cat#860077
4-phenylbutirric acid (4-PBA) Sigma Aldrich Cat#SML0309
Margatoxin (MgTx) Alomone Lab Cat#STM-325
Charybdotoxin (ChTx) Alomone Lab Cat#STC-325
Stichodactylatoxin (ShK) Alomone Lab Cat#STS-400
PAPTP Leanza et al., 2017 N/A
PCARBTP Leanza et al., 2017 N/A
DMSO Sigma Aldrich Cat#D2650
TRIzoL Thermo Fisher Scientific Cat#15596026
D-Luciferin Sigma Aldrich Cat#L9504
Chlorophenolred- b -D-galactopyranoside (CPRG) Roche Cat#10884308001
2-deoxy-D-glucose Sigma Aldrich Cat#D8375
TransIT-LT1 transfectionreagent Mirus Cat#MIR2304
Coelenterazine Santa Cruz Biotechnologies Cat#sc-205904
Ionomycin Sigma Aldrich Cat#I3909
Critical Commercial Assays
CellTiter 96 AQUEOUS One solution Promega Cat#G3581
Superscript reverse transcriptase kit Thermo Fisher Scientific Cat#12594025
ATP Lite luminescence ATP detection assay system Perkin Elmer Cat#6016947
Power SYBR Green PCR master mix Thermo Fisher Scientific Cat#4367659
Experimental Models: Cell Lines
Human: HEK293 ATCC CRL-1573
Human: DLD1 ATCC CCL-221
Human: HCT116 ATCC CCL-247
Human: HeLa ATCC CCL-2
Human immortalized fibroblasts bcs1lwt/wt Fernandez-Vizarra et al., 2007 N/A
Human immortalized fibroblasts bcs1lR73C/F368I Fernandez-Vizarra et al., 2007 N/A
Experimental Models: Organisms/Strains
Zebrafish: Tg(7xTCFX.lasiam:mCherry)ia5 Moro et al., 2012 ZFIN: ZDB-alt-110113-2
Zebrafish: Tg(7xTCFX.lasiam:GFP)ia4 Moro et al., 2012 ZFIN: ZDB-alt-110113-1
Zebrafish: Tg(12xGli.HSV:GFP)ia11 Costa et al., 2017 ZFIN: ZDB-alt-120404-2
Zebrafish: Tg(Olig2:gfp)vu12 Shin et al., 2003 ZFIN: ZDB-alt-041129-8
Zebrafish: Tg(Gata1:dsred)sd2 Traver et al., 2003 ZFIN: ZBD-alt-051223-6
Oligonucleotides
hGAPDH (for): CACAATATCACTTTACCAGAGTTAAAAGC This paper N/A
hGAPDH (rev): CGAGCCACATCGCTCAGAC This paper N/A
hb-catenin (for): CGAATGTCTGAGGACAAGCCACA This paper N/A
hb-catenin (rev): CCATATCCACCAGAGTGAAAAGA This paper N/A
hCyclin D1 (for): GGGGAGGAGAACAAACAGAT This paper N/A
hCyclin D1 (rev): TGAGGCGGTAGTAGGACAGG This paper N/A
hDKK1 (for): CAGGCGTGCAAATCTGTCT This paper N/A
hDKK1 (rev): CCCATCCAAGGTGCTATGAT This paper N/A
hAxin1 (for): ACAGGATCCGTAAGCAGCAC This paper N/A
hAxin1 (rev): GCTCCTCCAGCTTCTCCTC This paper N/A
Recombinant DNA
M50 Super 8x TOPFlash Addgene Cat#12456
RBPJ-lux Gift from Prof. C. Kintner N/A
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8xGTIIC-luciferase Addgene Cat#34615
F-XBP1DDBD Gift from Prof. T. Iwawaki N/A
CMV-lux Gift from Prof. A. Rosato N/A
CMV-b-gal Azzolin et al., 2012 N/A
stable b-catenin expressing vector Azzolin et al., 2012 N/A
pRK5-mWnt3a Addgene Cat#42277
pBlueScript II SK (+) Addgene Cat#212205
NDE Gift from Prof. C. Kintner N/A
aequorin construct targeted to the ER (erAEQ) Ottolini et al., 2014 N/A
MFN2-overexpressing plasmid Cieri et al., 2018 N/A
Software and Algorithms
Image Lab BioRad Laboratories N/A
Prism 6.0 Graph Pad N/A
GIMP 2.0 https://www.gimp.org N/A
iQiCycler BioRad Laboratories N/A
O2 View Hansatech Instruments N/ALEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for reagents may be directed to and will be fulfilled by the corresponding author Luigi Leanza (luigi.
leanza@unipd.it).
This study did not generate new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal studies
Zebrafish (animals and embryos) were maintained according to standard rules and procedures (https://zfin.org). All animal manipu-
lation procedures were conducted according to the Local Ethical Committee at the University of Padua and National Agency (Italian
Ministry of Health Authorization number 407/2015-PR), and with the supervision of the Central Veterinary Service of the University of
Padova (in compliance with Italian Law DL 116/92 and further modifications, embodying UE directive 86/609).
Cell cultures
In vitro experiments were performed with HEK293, HeLa, HCT116 and DLD1 cells. HEK293, HeLa and HCT116 cells were cultured in
Dulbecco’s modified Eagle medium (DMEM, Invitrogen), supplemented with 10% fetal bovine serum (FBS, BioSpa S.p.A.), 10 mM
HEPES (Life Techologies), 100 U/ml penicillin and 100 U/ml streptomycin (Life Technologies), 1X non-essential amino acids (Life
Technologies). DLD1 cells were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium (Invitrogen), supplemented with
10% fetal bovine serum (FBS, BioSpa S.p.A.), 10 mM HEPES (Life Techologies), 100 U/ml penicillin and 100 U/ml streptomycin
(Life Technologies), 1X non-essential amino acids (Life Technologies). All cells were maintained at 37C and 5% CO2. Furthermore,
we used human immortalized fibroblasts obtained from healthy human subjects harboring a gene codifying the respiratory chain
complex III assembly factor bcs1lwt/wt (wt) or from a patient with deficiency of the respiratory chain complex III, due to a bcl1s
composed heterozygosis (bcs1lR73C/F368I) (Fernandez-Vizarra et al., 2007). These human cells were maintained in culture in
DMEM supplemented as stated above.
METHOD DETAILS
Reagents
The following compoundswere obtained fromSigma-Aldrich: CHIR99021 and XAV939, twoWnt signalingmodulators; cyclopamine, an
inhibitor of the Sonic-Hedgehog pathway; DAPT, a Notch inhibitor; Forskolin and 3-isobutyl-1-methyl-xanthine (IBMX), used to block
Hippopathway; valinomycin, a potassium ionophore; salinomycin and nigericin, two potassiumantiporters; rotenone, 2-Thenoyltrifluor-
oacetone (TTFA), antimycin A, oligomycin, the respiratory chain complexes inhibitors; the mitochondrial uncoupler FCCP (Carbonyl cy-
anide-p-trifluoromethoxyphenylhydrazone); atractyloside, a blocker of the mitochondrial adenine nucleotide transporter (ANT); the
SERCA inhibitor thapsigargin; tunicamycin, an inducer of the unfolding protein response (UPR); Creatine and phosphoenolpyruvate,
to stimulate cellular ATP production; 4-phenylbutirric acid (4-PBA), an inhibitor of ER stress; staurosporine, an inducer of the intrinsicCell Reports 28, 1949–1960.e1–e6, August 20, 2019 e3
apoptotic pathway, PAP-1, a membrane permeant inhibitor of the potassium channel Kv1.3. Margatoxin (MgTx), Stichodactyla toxin
(ShK) and Charybdotoxin (ChTx) were from Alomone Lab. The mitochondria-targeted Kv1.3 inhibitors (3-(4-(4-((7-oxo-7H-furo[3,2-g]
benzopyran-4-yl)oxy)butoxy)phenyl)propyl)triphenyl phosphonium iodide (PAPTP) and (3-(((4-(4-((7-oxo-7H-furo[3,2-g]benzopyran-4-
yl)oxy)butoxy)phenoxy)carbonyl) amino) propyl) triphenylphosphonium iodide (PCARBTP) were synthesized as described previously
(Leanza et al., 2017). All compounds were dissolved in DMSO. In HEK293 cells, Wnt signaling is not active, thus it was induced with
CHIR99021, awell-establishedWnt signaling activator that acts by inhibitingGSK3b activity (Ring et al., 2003), hence favoring b-catenin
stabilization, or by transfectionwith a plasmid expressing theWnt3A ligand. Consequently, cells treatedwith 0.2%DMSOwere used as
a negative control and cells treated with 3 mM CHIR99021 were considered the positive control.
Protein lysates and electrophoresis
Total protein extracts were obtained from cells. After removing the culture medium, cells were washed twice in ice-cold phosphate
buffer saline (PBS), detached and resuspended in 1.5 mL of PBS and transferred into a 2 mL Eppendorf tube. After 5 minutes of centri-
fugation at 1,200 g, the pellet was resuspended in 600 mL of ice-cold lysis buffer (0.3X PBS, 0.5% Triton X-100, 0.5% Sodium Dodecyl
Sulfate), vortexed for 20 s and then centrifuged at 20000 g for 20minutes at 4C. The supernatant, containing proteins, was transferred
to a new eppendorf tube and stored at 80C until use. Proteins were separated by sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE). All gels usedwereNuPage 4%–12%Bis-Tris protein gels fromThermoFisher Scientific usingNuPageMES as
running buffer (Thermofisher Scientific). Protein lysates were pre-incubated with Laemmli sample buffer and loaded into the wells. Pag-
eRuler Plus Prestained Protein Ladder (Thermofisher Scientific) was loaded in the first lane as molecular weight standard.
Western Blotting
Western Blot was performed with PVDFmembranes. 50 mg of protein were loaded in each lane of 4%–12%NuPage Bis-Tris precast
gels (Thermo Fisher Scientific – NP0321BOX). The transfer was performed with NuPage Transfer Buffer. Membranes were blocked in
skim milk (Sigma-Aldrich, 5% in Tris-buffered saline (TBS: 10 mM Tris, 150 mM NaCl, pH 7.4) for 2 hours at RT and washed in
TBS. Membranes were incubated overnight at 4C with the following primary antibodies all diluted in TBS-Tween (TTBS: TBS +
0.05% Tween (Sigma-Aldrich) 20%): b-catenin (1:2000 - Sigma-Aldrich C7082); b-catenin pS552 (1:1000 - CST #9566); MET
(1:1000 - CST #8198); LEF1 (1:500 - CST #2230); CD44 (1:1500 - CST #3570); GSK3a/b (1:1000 - CST #5676); GSK3a/b pS21/9
(1:1000 - CST #8566); Wnt5a/b (1:1500 - CST #2530); NFATc1 (1:1000 - SCBT sc-7294); Akt (1:1000 - CST #9272); Akt
pS473 (1:1000 - CST #4060); ACC pS79 (1:500 - SCBT sc-271965); BiP (GRP78 – 1:1000 - CST #3183); eIF2a pS51 (1:1000 - Abcam
ab32157); eIF2a (1:1000 – Abcam ab5369); ATF4 (1:500 - SCBT sc-200); TCF7 (1:1000 – Sigma-Aldrich WH0006932M1);
GAPDH (1:1000 - EMD Millipore CB1001); b-actin (1:3000 - EMD Millipore MAB1501); MFN2 (1:1000 – abnova H00009927-M03);
SERCA (1:2000 - Thermo Fisher Scientific MA3-910); Calnexin (1:5000 – Stressgen SPA-860); Calreticulin (1:2000 – Stressgen
SPA-601). Anti-mouse or anti-rabbit secondary antibodies conjugated to horseradish peroxidase (HRP; dilution 1:10000 in TTBS;
mouse: Sigma-Aldrich A4416; rabbit: KPL 074-1516) were used for protein detection. Chemiluminescence was detected with Chem-
iDoc Touch Imaging System (BioRad) after incubation with EuroCloneLiteAblot Plus luminol mix. Densitometric analyses were per-
formedwith Image LabSoftware (BioRad). b-actin or GAPDHwere used as loading controls. Statistical analyseswere performedwith
GraphPad Prism 5.
Real-Time PCR
RNA extraction was performed with TRIzol (Thermofisher Scientific), following themanufacturer’s protocol. Total RNAwas quantified
with NanoDrop 2000 Spectrophotometer (Thermofisher Scientific). SuperScript II Reverse Transcriptase kit (ThermoFisher Scientific)
was used for retrotranscription, as indicated by the supplier, usingMastercycler (Eppendorf). The synthetized cDNAwas subjected to
RT-PCR with Power SYBR Green PCR Master Mix (ThermoFisher Scientific) following supplier’s instructions. iQiCycler (BioRad)
was used for the amplification reaction and plate reading. Gapdh was used as housekeeping gene for normalization.
Primers for RT-PCRTarget Sequence (from 5‘ to 3‘) Accession number
hGAPDH (for) CACAATATCACTTTACCAGAGTTAAAAGC NM_002046.5
hGAPDH (rev) CGAGCCACATCGCTCAGAC NM_002046.5
hb-catenin (for) CGAATGTCTGAGGACAAGCCACA NM_001904.3
hb-catenin (rev) CCATATCCACCAGAGTGAAAAGA NM_001904.3
hCyclin D1 (for) GGGGAGGAGAACAAACAGAT NM_053056.2
hCyclin D1 (rev) TGAGGCGGTAGTAGGACAGG NM_053056.2
hDKK1 (for) CAGGCGTGCAAATCTGTCT NM_012242.2
hDKK1 (rev) CCCATCCAAGGTGCTATGAT NM_012242.2
hAxin1 (for) ACAGGATCCGTAAGCAGCAC NM_003502.3
hAxin1 (rev) GCTCCTCCAGCTTCTCCTC NM_003502.3
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MTS assay
Tomeasure viability of the cells, HEK293, HCT116 and DLD1 cells were seeded into 96-well plates at a density of 203 103 cells/well.
After 24 hours, the growth medium was replaced with phenol red- and FBS-free medium and treated with the drugs: four wells were
used for each condition. After 8 or 24 hours of incubation with different drugs 10% CellTiter 96 AQUEOUS One solution (Promega,
Italy) was added to each well. Finally, absorbance at 490 nm was measured using an Infinite 200 PRO 96-well plate reader. Since
the assay is based on dehydrogenase activity, that is inhibited by TTFA (Guzzo et al., 2014), the MTT absorbance is lower in the pres-
ence of the drug. We therefore controlled by addition of FITC-labeled annexin V that cells after TTFA treatment were not dead
(not shown).
Luciferase assays
Luciferase assayswere performed in HEK293, HCT116 andDLD1 cell lines. Cells were transfectedwith one of the following plasmids:
b-catenin/TCF-responsive reporter TOP-FLASH (M50 Super 8x TOPFlash, Addgene, Cat#12456), YAP/TAZ-responsive reporter
8xGTIIC-Lux (Addgene, Cat#34615), Notch-responsive reporter RBPJ-Lux (a gift from Prof. C. Kintner), ER-stress responsive re-
porter F-XBP1DDBD (a gift from Prof. T. Iwawaki). Transfection performed with CMV-Lux (a gift from Prof. A. Rosato) reporter
was used as control. To induceWnt signaling in some experiments, cells were transfected together with stable b-catenin expressing
vector (Azzolin et al., 2012) or Wnt3a expressing construct (pRK5-mWnt3a, Addgene, Cat#42277). To induce Notch signaling, co-
transfection with NDE (a gift from Prof. C. Kintner) was performed. Luciferase reporters were transfected together with CMV-b-gal
(Azzolin et al., 2012) to normalize for transfection efficiency with CPRG (Roche). DNA content was kept uniform by using pBlueScript
II SK (Addgene, Cat#212205).
Cells were plated in 24-well plates at a density of 5 3 104 cells/well. After 24 hours luciferase reporter plasmids were transiently
transfected using TransIT-LT1 Transfection Reagent (Mirus). 48 hours after transfection, cells were treated with different com-
pounds for 8 hours and then harvested in Luc lysis buffer (25 mM Tris pH 7.8, 2.5 mM EDTA, 10% glycerol, 1% NP-40, 2 mM
DTT). Luciferase activity was determined in a Tecan plate luminometer with freshly reconstituted assay reagent (0.5 mM D-Luciferin,
20 mM tricine, 1 mM (MgCO3)-4Mg(OH)2, 2.7 mM MgSO4, 0.1 mM EDTA, 33 mM DTT, 0.27 mM CoA, 0.53 mM ATP).
The luciferase signal was normalized with respect to the b-gal signal that was used to co-transfect the cells, as normalization of the
luciferase signal with respect to the cell number would not take into consideration that not all cells are transfected. Thus, the
measured luciferase signal refers only to the transfected and living cells (otherwise b-gal would not be expressed) as previously
described (Azzolin et al., 2014; Dupont et al., 2011).
Determination of ATP concentration
ATP amount wasmeasured in HEK293, in HCT116, in DLD1 and in human immortalized fibroblasts, using ATPlite Luminescence ATP
Detection Assay System (Perkin Elmer). Cells were seeded into white 96-well viewplates at a density of 43 104 cells/well for HEK293
and HCT116, 33 104 cells/well for DLD1 and 1.53 104 cells/well for human immortalized fibroblasts. Tomeasure mitochondrial ATP
production, 24 hours after seeding glycolysis was inhibited pre-incubating cells with 5.5 mM 2-deoxy-D-glucose (2-DG) for 1 h and
then all treatments were performed in medium containing 2-DG. Oligomycin was used as positive control. 6 hours after treatments,
the assay was performed according to manufacturer’s instructions.
In vivo experiments
WTzebrafishwere from the T€ubingen (T€u) or AB strains. All transgenic lineswere collected fromoriginal laboratories which developed
the lines and are currently stabled at the zebrafish facility of University. All transgenic lineswere previously reported, Sonic-Hedgehog
(Shh) reporter Tg(12xGli.HSV:GFP)ia11 (ZFIN: ZDB-alt-120404-2), Tg(Olig2:gfp)vu12 (ZFIN: ZDB-alt-041129-8) (Moro et al., 2012),
Tg(Gata1:dsred)sd2 (ZFIN: ZBD-alt-051223-6) (Shin et al., 2003). Tg(7xTCFX.lasiam:EGFP)ia4 contains a gfp gene driven by a tcf./lef
responding promoter. This line reports Wnt signaling activity in vivo. Tg(Olig2:GFP)vu12 contains gfp gene under control of a fragment
derived from the oligodendrocyte transcription factor 2 (Olig2) promoter region, this line accounts for olig2 transcription in vivo (Traver
et al., 2003). Tg(gata1:dsRed)sd2 transgene contains the dsRed cDNA under control of a 7-kb fragment derived from the gata1 pro-
moter (Traver et al., 2003). This line reports all erythroid lineages (Gata1+) in vivo.
Zebrafish embryos expressing fluorescent proteins were analyzed using a Leica M165FC epifluorescent microscope. All images
were acquired with a Nikon DS-F12 digital camera. All images were acquired with the same exposure parameters and processed in
silicowith GIMP 2.0. Western blot experiments, fish larvae were lysed in buffer (50 mM Tris pH 7.5, 150 mMNaCl, 0.02%NP-40 sup-
plemented with protease inhibitor (Roche Diagnostics) and Phosphatase Inhibitor Cocktails 2 and 3 (Sigma-Aldrich). Sample homog-
enization was performedwith a glass dounce. The lysates were centrifuged at 13000 g for 30min at 4C. Supernatants were analyzed
by SDS-PAGE/WB as described above.
Morpholinos injection, Oxygraph analysis and rescue
Custom Morpholinos were purchased by Genetools LLC. Bcs1l spMO (50-AGCACAACAGCAAGACATACTCTCG-30) affects splicing
donor site of the exon 5 in D. rerio bcs1l mRNA(-). Ttc19 spMO (50-AAGGCTGATGTGAAAGCAAATCTGA-30) affects exon 2 splicing
acceptor site in D. rerio ttc19 mRNA. Standard Ctrl Morpholino (Ctrl MO) was purchased by Genetools LLC. Microinjection is per-
formed on randomly separated sibling embryos at 1 cell stage, adding z30ng/embryos of morpholino. Chorions were manuallyCell Reports 28, 1949–1960.e1–e6, August 20, 2019 e5
excided at 24hpf and images were acquired at 48hpf, crude proteins extract were also obtained after images acquisition (See section
above). Respiratory deficiency was assessed by Oxygraph+ (Hansatech instruments), O2 concentration in the media and O2 con-
sumption were revealed by O2 view software. 15 randomly selected embryos were displayed in the sample chamber (2ml fish water,
28C, 50rpm), recording started after a stabilization period of 180 s, acquisition was performed for 780 s. Pictures report 300 s of a
single experiment with Ctrl MO; Bcs1l spMO; Ttc19 spMO, 3 independent experiments were performed for each condition. O2 con-
centration in the media and O2 consumption reported in graphs show pooled data from three independent experiments and paired
t test has been performed (* = p < 0.05). Recovery experiments were performed by the co-injection in siblings’ embryos at 1 cell stage
of 650 ng/larva of Creatine (Sigma Aldrich) and 30 ng/larva of splicing morpholino. Pictures acquisition were performed at 48hpf by
Leica M165FC epifluorescent microscope. A single embryo representative of 3 different independent experiments was reported in
each picture.
ER-mitochondria Contact Site Analysis
Cells plated on 13-mm-diameter coverslips were transfected with SPLICSS (Cieri et al., 2018) together with empty or MFN2 express-
ing vector. We have previously developed this splitGFP and BICF-based probe to specifically monitor ER-mitochondria contacts in
the range of 8-10 nm (Cieri et al., 2018), i.e., those that are occurring at the distance range suitable tomodulate ER-mitochondria Ca2+
transfer ((Csorda´s et al., 2010; Giacomello et al., 2010). Fluorescence was analyzed in living cells by a Leica SP5 confocal micro-
scope. Cells were excited at 488 nm and confocal stacks were acquired every 0.2 mm along the z axis with a 63 3 objective. For
mitochondria-ER interaction analysis, stacks were automatically analyzed using ImageJ, deconvoluted, three-dimensional-recon-
structed, and surface-rendered by using VolumeJ (ImageJ). Interactions were quantified as already described (Cieri et al., 2018).
Calcium uptake measurements
HEK293 or HeLa cells were seeded onto 6-well plates 12 h before transfection and allowed to grow to 60%–80% confluence. Trans-
fection was carried out with the Ca2+-phosphate procedure, using 12 mg for each well of the 6-well plate. For Ca2+measurement cells
were co-transfectedwith low affinity aequorin construct targeted to the ER (erAEQ) alone or together withMFN2-overexpressing vec-
tor (Ottolini et al., 2014). Twenty-four hours after transfection, cells were plated onto a 96-well plate. The day after, HEK293 cells were
incubated for 8 hours with the different drugs before Ca2+ measurements. Ca2+ concentration measurements were carried out in a
Perkin-Elmer Envision plate reader equipped with a two-injectors unit.
To measure steady state Ca2+ levels in the lumen of the ER, transfected aequorin needs to be reconstituted in its active form by
adding the prosthetic group coelenterazine. Considering the high amount of Ca2+ in the ER lumen, to obtain sufficient amount of re-
constituted aequorin and to avoid the consumption before starting the measurements, it is necessary to drastically reduce ER Ca2+
content. Thus, the cells were incubated for 1.5 h at 4C in modified Krebs Ringer Buffer (KRB: 125 mM NaCl, 5 mM KCl,
400 mM KH2PO4, 1 mM MgSO4, 20 mM HEPES, pH 7.4) supplemented with 5 mM glucose, 5 mM of the Ca
2+ ionophore ionomycin
(Sigma), 600 mM EGTA and 5 mM of the hydrophobic prosthetic group coelenterazine n (Santa Cruz Biotechnology). Cells were then
extensively washed with KRB supplemented with 2%bovine serum albumin (Sigma) and 1mMEGTA to remove ionomycin and were
placed in 70 mL of KRB supplemented with 5 mM glucose and 75 mM EGTA and luminescence from each well was measured. After
10 s, 1 mMCaCl2 at the final concentration was injected to refill the ER lumen. After Ca
2+ re-addition, a plateau was reached in about
two minutes and its level, reported upon calibration of photons emission in Ca2+ concentration values was indicative of the steady
state Ca2+ level in the ER. To calibrate photons emission in Ca2+ concentration values, the total amount of active aequorin in each
coverslip needs to be discharged (Brini et al., 1995). Thus, the experiments were terminated by lysing the cells with 100 mM digitonin
(Sigma) in a hypotonic Ca2+-rich solution (10 mM CaCl2 in H2O) to consume the remaining reconstituted aequorin pool. Output data
were analyzed and calibrated with a custom made macro-enabled Excel workbook as previously described (22).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistically significant difference was assessed for each treatment by means of one-way ANOVA analysis with Dunnett’s post test.
All statistical analyses were performed using GraphPad Prism software. Statistical details can be found in all figure legends.
DATA AND CODE AVAILABILITY
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Supplementary Figure legends. 
Figure S1. Mitochondrial fitness does not affect other signaling pathways in vitro and in vivo. Related to 
Figure 1. (A) A representative Western blot showing protein levels of β-catenin after 8 hours treatment with 
0.1% DMSO (used as negative control), 1μM PAPTP with (+) or without (-) 3 μM CHIR. 50 µg of protein extract 
from HEK293 cells were loaded. β-actin was used as loading control. (B) Viability of HEK293 cells was assayed 
after 8 hours of treatment with MTS assays, to confirm sub-lethal dosage of the compounds after the 8 hours-
treatment used throughout the study. Cells were treated with the following compounds: 0.1% DMSO, as 
negative control; 10% DMSO as positive controls; 3 µM CHIR99021 (CHIR); 10 µM XAV939 (XAV); 1 µM PAPTP 
and 5 µM PCARBTP, mitochondrial Kv1.3 inhibitors; potassium fluxes modulators, 5 µM salinomycin (Salino), 
1 µM valinomycin (Valino), 0.5 µM nigericin (Nige); 2 µM of the uncoupler FCCP; respiratory chain complexes 
inhibitors, 5 µM rotenone (Rot), 0.5 mM TTFA, 10 µg/ml antimycin A (Anti), 1 µg/ml oligomycin (Oligo); 1 µM 
SERCA inhibitor thapsigargin (Thapsi) and 0.5 µg/ml UPR-inducer tunicamycin (Tunica); 10 µM of the adenine 
nucleotide transporter (ANT) blocker atractyloside (Atracty). The values are reported as means of 
percentages +/- SEM of MTS absorbance measured at 490 nm related to DMSO-treated samples, indicated 
in the graph as “ref” (n=3). (C) To verify that the decrease in luciferase signal was not directly due to inhibition 
of enzymatic activity upon treatment with the different drugs but was dependent on the modulation of a 
signaling pathway, HEK293 cells were transfected with a plasmid encoding a luciferase under the control of 
the CMV promoter. Then cells were treated for 8 hours as in S1B. The values are reported as means of 
percentages of luciferase signal +/- SEM related to DMSO treated sample, indicated in the graph as “ref” 
(n=3). (D-E) Canonical Wnt signaling activity based on TCF/LEF dependent transcription was assayed in 
HEK293 cells, which were transfected with a TOP-FLASH plasmid codifying a luciferase reporter gene under 
the control of a TCF/LEF promoter. In these cells we either induced or not the Wnt signaling by co-transfection 
with stable β-catenin- (D) or Wnt3A-expressing (E) plasmids. Furthermore, HEK293 cells were treated for 8 
hours with the compounds as in S1B. The values are reported as percentage of luciferase signal related to 
the induced control indicated in the graph as “ref”. Values are means +/- SEM (n=3). (F-G) The specificity for 
the mito-Wnt axis was further demonstrated by the in vitro study of other two signaling pathways, namely 
Notch (F) and Hippo (G). The Notch signaling was assayed by co-transfecting HEK293 cells with both a RBPJ-
lux plasmid codifying luciferase under the control of a Notch-dependent promoter and the NΔE plasmid to 
induce this signaling pathway. Conversely, the Hippo pathway activity was measured by transfecting cells 
with the 8xGTIIC luciferase reporter plasmid. As positive controls, DAPT for the Notch pathway and Forskolin 
and 3-isobutyl-1-methyl-xanthine (IBMX) for the Hippo pathway were used. Cells were treated for 8 hours as 
stated before in S1B. The values are reported as means of percentages of luciferase signal +/- SEM related to 
NΔE+DMSO (F) or DMSO (G) treated samples, indicated in the graph as “ref” (n=4). (H) Real-time PCR analysis 
of the transcription of β-catenin, Dickkopf (DKK1), Cyclin D1 and Axin1 in cells treated with 0.2% DMSO, 0.1% 
DMSO + 3 µM CHIR, 5 µM salinomycin + 3 µM CHIR, or 1 µM PAPTP + 3 µM CHIR. DMSO was used as negative 
control. All values were normalized on GAPDH expression. The values are reported as means of percentages 
of RNA expression +/- SEM related to DMSO + CHIR treated samples, indicated in the graph as “ref” for each 
gene (n=4). (I-K) GFP fluorescent Zebrafish Tg(12xGli.HSV:GFP)ia11 Sonic Hedgehog (Shh) reporter fish (P), 
Tg(Olig2:GFP)ek23 Oligodendrocyte reporter fish (Q), and dsRED fluorescent Tg(gata1:dsRed)sd2 erythroid 
transcription factor Gata 1 reporter fish (R) were treated at 15 hpf for 15 hours with the following 
compounds: 3 µM CHIR; 10 µM cyclopamine (Cyclop), an inhibitor of the Shh pathway; 1 µM salinomycin 
(Salino); 1.5 µM PAPTP; 5 µM PCARBTP; 1 µM thapsigargin (Thapsi). DMSO 0.2 % was used as negative 
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control. Fluorescence quantification in the different animals, determined by GIMP 2.0 software, is shown. 
The lines represent the mean of the values +/- SEM related to DMSO treated samples, indicated as “ref” in 
the graphs. The number reported on the graphs represent the number of zebrafish embryos treated for each 
condition. For all the panels statistical significance (ANOVA) was determined (* = p<0.05; **=p<0.01; 
***=p<0.001). 
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Figure S2. Other signaling pathways and non-canonical Wnt signaling are not activated by mito-Wnt axis. 
Related to Figure 2. (A) β-catenin phosphorylation in the serine 552 was observed by Western blot using 50 
µg of total proteins extract from HEK293 cells treated as in S1B. A representative blot for the phosphorylated 
β-catenin protein is shown in the left panel, while the quantification of four independent experiments is 
reported on the right. β-actin was used as loading control. Values in the quantification are means of 
percentages +/- SEM related to the DMSO + CHIR treated sample, indicated as “ref”. (B) AMPK activation was 
determined using the ACC phosphorylation on its serine 79 as readout. 50 µg of total protein extract from 
HEK293 cells treated as in S1B were analyzed by SDS-PAGE and then Western blot using a pS79 ACC antibody. 
Oligo was used as positive control, β-actin as loading control. A representative blot for the phosphorylated 
ACC protein antibody is shown on the left panel, while the quantification of three independent experiments 
is reported on the right. (C) Non-canonical Wnt signaling was measured by evaluating the expression of the 
Wnt5 ligand or the transcription factor NFATC1. Their expression was evaluated by Western Blot using 50 µg 
of total protein extracts from HEK293 cells treated as in S1B. β-actin was used as loading control. 
Representative blots for the Wnt5 or NFATC1 antibodies are shown in the upper panel, while the 
quantification of three independent experiments are reported below. (D) ER Ca2+ levels in HEK293 cells after 
6 hours of treatment with the indicated compounds used as in figure 1A or 2A. Representative traces of the 
ER calcium reuptake are shown in the left panel, while the quantification at steady state is reported on the 
right (n=3; mean +/- SEM). The values are reported as Ca2+ concentrations, and analysis is related to the 
DMSO or 2-DG sample. (E-G) Effects of MFN2 WT overexpression on ER-mitochondria contacts. (E) 
Representative Western blotting analysis of MFN2, SERCA, Calnexin and Calreticulin overexpression in Hela 
cells wt or overexpressing MFN2. A representative blot is shown on the left panel, while the quantification 
of three independent experiments is reported on the right; (F) Representative confocal pictures of HeLa cells 
expressing SPLICSS alone (upper panel) or along with MFN2 WT (bottom panel). The green channel is the 
merge of several planes and refers to the signal emitted at 488 nm upon SPLICSs reconstitution. Scale bar 20 
µm. Quantification of ER-mitochondria short contacts by 3D rendering of complete z-stacks is shown in the 
graph on the right (Ctrl, 60.7±5.3, n=40, 85.0 ±7.6 n=29, p<0.01). (G) ER Ca2+ measurement with ER-targeted 
low affinity aequorin. Upon ER Ca2+ depletion (see Material and Methods for details), the cells were perfused 
with KRB buffer containing 1mM CaCl2 and the ER refilling was monitored. As shown in the Figure, after about 
2 min a plateau is reached and it is indicative of the steady state Ca2+ concentration level in the ER lumen. 
The traces are representative of three independent experiments ([Ca2+]ER mM, 168 ± 16.7 n=4 for CTRL and 
227 ± 15.0 n=10 for MFN2 overexpressing cells p<0.05). (H) ER stress induction in HEK293 cells after the 
treatment as in S1B was further demonstrated by the induction of BiP shown by Western blot using 50 µg of 
total proteins extract per lane. A representative blot for the anti BiP antibody is shown on the left, while the 
quantification of three independent experiments is reported on the right. β-actin was used as loading control.  
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Figure S3. Other signaling pathways and non-canonical Wnt signaling are not activated by mito-Wnt axis. 
Related to Figure 2. (A-B) Total Akt, Akt phosphorylation in serine 473, total GSK3β and GSK3β 
phosphorylation in serine 9 protein expression were evaluated by Western Blot using 50 µg of total proteins 
extract from HEK293 cells treated as in S1B after Wnt induction by Wnt3A plasmid transfection. β-actin was 
used as loading control. Representative blots are shown in A, while the quantification of three independent 
experiments is reported in B. (C) The ratio between the phosphorylated Akt (Akt pS473) or GSK3β (GSK3β 
pS9), as obtained in E, and the total Akt or GSK3β was quantified. Values in the quantification are means of 
percentages +/- SEM related to the DMSO+Wnt3A treated samples, indicated as “ref”. For all the panels 
statistical significance (ANOVA) was determined (*=p<0.05; **=p<0.01; ***=p<0.001). 
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Figure S4. Wnt signaling is down-regulated in colorectal cancer cells. Related to Figure 2. (A) Mitochondrial 
ATP content was measured in HCT116 cells after treatment with the indicated compounds at the 
concentration used in figure 2G. Cells were treated in a fresh medium containing 5 mM 2-deoxyglucose (2-
DG) instead of glucose, in order to block glycolysis. The values are reported as percentage of luciferase signal 
related to the DMSO sample, used as negative control, and specified in the graph as “ref”. Values are means 
+/- SEM (n=4). Oligo was used as positive control. (B) Viability of HCT116 cells was assayed after 24 hours of 
treatment with MTS assays, to confirm sub-lethal dosage of the compounds after the 8 hours-treatment used 
throughout the study. Cells were treated as in 2G. DMSO 10% was used as positive control. To better evaluate 
the effect of Anti, HCT116 cells were treated for 8 hours and then Annexin-V staining was performed to 
confirm that cell viability was not affected (data not shown). The values are reported as means of percentages 
+/- SEM of MTS absorbance measured at 490 nm related to DMSO-treated samples, indicated in the graph 
as “ref” (n=3). (C) Quantification of protein expression in HCT116 cells analyzed by Western Blot as reported 
in figure 2I. Values in the quantification from four independent experiments are means of percentages +/- 
SEM related to the DMSO treated samples, indicated as “ref”. (D) Viability of DLD1 cells was assayed after 24 
hours of treatment with MTS assays, to confirm sub-lethal dosage of the compounds after the 8 hours-
treatment used throughout the study. Cells were treated as in 2G. DMSO 10% was used as positive control. 
The values are reported as means of percentages +/- SEM of MTS absorbance measured at 490 nm related 
to DMSO-treated samples, indicated in the graph as “ref” (n=4). (E) Canonical Wnt signaling activity based on 
TCF/LEF dependent transcription was assayed in DLD1 cells as in 2G for 8 hours. Analysis was performed as 
in 2G. Values are means +/- SEM (n=8). (F) Mitochondrial ATP content was measured in DLD1 cells after 
treatment with the indicated compounds at the concentration used in figure S2K. Cells were treated in a 
fresh medium containing 5 mM 2-deoxyglucose (2-DG) instead of glucose, in order to block glycolysis. The 
values are reported as percentage of luciferase signal related to the DMSO sample, used as negative control, 
and specified in the graph as “ref”. Values are means +/- SEM (n=3). Oligo was used as positive control. (G) 
β-catenin and MET reduction and ER-stress induction were measured in DLD-1 cells (50 µg of protein 
extract/lane) by Western blot after treatment with the compounds as in S2K. β-actin was used as loading 
control. Quantification is reported on the right (n=4). Values in the quantification are means of percentages 
+/- SEM related to the DMSO treated sample, indicated as “ref”. For all the panels statistical significance 
(ANOVA) was determined (*=p<0.05; **=p<0.01; ***=p<0.001). 
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